EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Outcomes in gestational and non-gestational choriocarcinoma: A retrospective cohort study with nomograms and web tools

Sakhr Alshwayyat iD, Mahmoud Bashar Abu Al Hawa, Karam Maraqa iD, Tala Abdulsalam Alshwayyat, Mustafa Alshwayyat, Hamdah Hanifa iD, Tala Alsaghir

Women's Health · 2025

DOI: 10.1177/17455057251344386 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Women's Health, 2025. Verfasst von Sakhr Alshwayyat und 6 weiteren Autor:innen. Beteiligte Einrichtung: King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: Nomograms, Choriocarcinoma, Uterine Neoplasms, Choriocarcinoma, Non-gestational. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Choriocarcinoma (CC), a rare and aggressive form of cancer, is composed of cytotrophoblasts and syncytiotrophoblasts. It is present in two subtypes: gestational choriocarcinoma (GCC) and non-gestational choriocarcinoma (NGCC). Recognizing the disparities between GCC and NGCC is essential for the precise staging, prognosis, and determination of the primary treatment strategy.

Objective

This study aimed to differentiate clinical outcomes, treatment responses, and prognostic factors between GCC and NGCC and to introduce innovative tools for personalized treatment strategies.

Design

A retrospective cohort study with Survival Analysis and Nomogram Development.

Methods

We analyzed data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database and identified female patients diagnosed with GCC and NGCC between 2000 and 2020. The clinicopathological features of each group were compared using the chi-square test. Kaplan-Meier curves, log-rank tests, and Cox proportional hazard regression were used to assess overall survival and cancer-specific survival and to determine risk factors. The 5-year survival predicting nomogram was constructed, evaluated, and validated.

Results

The study included 919 patients with 719 CC and 200 patients with NGCC. The NGCC group was characterized by older age, a higher proportion of married individuals, more advanced disease stages, larger tumor sizes, and a higher frequency of surgical interventions than the GCC group. NGCC was associated with worse survival rates than GCC patients.

Conclusions

This study highlights the critical role of chemotherapy in improving the survival of patients with NGCC, in contrast to its limited effect on GCC. The negative prognosis associated with radiotherapy underscores the urgent need for further investigation to optimize its use. In addition, the introduction of the first web-based survival prediction tool and predictive nomogram marked a significant advancement in personalized treatment strategies, enabling improved clinical outcomes by tailoring therapy to individual patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsChoriocarcinomaUterine NeoplasmsChoriocarcinoma, Non-gestationalHumansFemaleRetrospective StudiesPregnancyAdultSEER ProgramMiddle AgedPrognosisInternetSurvival AnalysisKaplan-Meier Estimate

Stichwörter der Autor:innen

chemotherapyprecision medicineprognosissurvival analysis

Autor:innen und Institutionen

  • King Hussein Cancer Center, Amman, Jordan.
  • Princess Basma Teaching Hospital, Irbid, Jordan.
  • Applied Science Research Center, Applied Science Private University, Amman, Jordan.
  • Faculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
  • Faculty of Medicine, University of Kalamoon, Al-Nabk, Syria.
  • Department of Obstetrics and Gynecology, King Hussein Cancer Center, Amman, Jordan.

ORCID-Profile: Sakhr Alshwayyat, Karam Maraqa, Hamdah Hanifa

Zitieren

APA

Alshwayyat, S., Hawa, M. B. A. A., Maraqa, K., Alshwayyat, T. A., Alshwayyat, M., Hanifa, H., & Alsaghir, T. (2025). Outcomes in gestational and non-gestational choriocarcinoma: A retrospective cohort study with nomograms and web tools. Women's Health. https://doi.org/10.1177/17455057251344386

Vancouver

Alshwayyat S, Hawa MBAA, Maraqa K, Alshwayyat TA, Alshwayyat M, Hanifa H, et al. Outcomes in gestational and non-gestational choriocarcinoma: A retrospective cohort study with nomograms and web tools. Women's Health. 2025. doi:10.1177/17455057251344386

BibTeX
@article{Alshwayyat2025,
  author = {Alshwayyat, Sakhr and Hawa, Mahmoud Bashar Abu Al and Maraqa, Karam and Alshwayyat, Tala Abdulsalam and Alshwayyat, Mustafa and Hanifa, Hamdah and Alsaghir, Tala},
  title = {Outcomes in gestational and non-gestational choriocarcinoma: A retrospective cohort study with nomograms and web tools},
  journal = {Women's Health},
  year = {2025},
  doi = {10.1177/17455057251344386}
}
Kostenlos starten →